Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Fosamprenavir and Maraviroc in Healthy Volunteers
NCT00764465Phase 2Completed
- Sponsor
- Garden State Infectious Disease Associates
- Start
- Oct 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fosamprenavir and maraviroc in human immunodeficiency virus infection (HIV) (6 arms), sponsored by Garden State Infectious Disease Associates. Primary endpoints: Minimum Plasma Concentration at Day 14, Maximum Plasma Concentration at Day 14 and 1 more. Started Oct 2008; status: completed.
02
Drugs
fosamprenavirmaraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00764465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764465.